Penumbra

Yahoo Finance • 21 days ago

EY on the current state of the medtech industry

In 2025, the medical device industry saw a steady stream of dealmaking activity. Among the year’s largest transactions were Abbott’s acquisition of Exact Sciences for $21bn, Becton Dickinson (BD)’s $17.5bn divestment of its Biosciences & D... Full story

Yahoo Finance • 25 days ago

Abbott stock slips on guidance cut, ranks 10th in healthcare equipment Quant ratings

[Futuristic laboratory equipment. DNA research on computer screens] janiecbros/E+ via Getty Images Abbott Laboratories (ABT [https://seekingalpha.com/symbol/ABT]) kicked off Q1 2026 earnings season with a mixed report, where revenue grew... Full story

Yahoo Finance • 26 days ago

A Look At Boston Scientific (BSX) Valuation After The Penumbra Acquisition And Recent Shareholder Returns

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Boston Scientific overview and recent trading context Boston Scientific (BSX) develops medical devices across MedSurg and Cardiov... Full story

Yahoo Finance • last month

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—PEN, MPX, MCFT, and JHG

NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story

Yahoo Finance • last month

2 Reasons to Avoid PEN and 1 Stock to Buy Instead

While the broader market has struggled with the S&P 500 down 3.2% since September 2025, Penumbra has surged ahead as its stock price has climbed by 32.3% to $335.10 per share. This was partly due to its solid quarterly results, and the run... Full story

Yahoo Finance • 2 months ago

Moderna stands as the best performing large-cap healthcare stock YTD

[Heart Health Concept] Eoneren/E+ via Getty Images U.S. large-cap healthcare stocks have delivered modest year-to-date gains in 2026, holding steady into March amid its defensive appeal. Below is a list of the top 10 large-cap healthcare... Full story

Yahoo Finance • 2 months ago

What Makes Penumbra (PEN) a Good Investment Choice?

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise ch... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC is Investigating Whether PEN, BCO, AES are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 2 months ago

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—THR, PEN, BCO, and ALGT

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in t... Full story

Yahoo Finance • 2 months ago

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—PEN, STKL, LNKB, and VCIC

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in t... Full story

Yahoo Finance • 3 months ago

Liberty All-Star® Growth Fund, Inc. January 2026 Monthly Update

BOSTON, February 14, 2026--(BUSINESS WIRE)--Below is the January 2026 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG). Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update, January 2026 Investment Approach... Full story

Yahoo Finance • 3 months ago

Why Boston Scientific Stock Plummeted Today

Key Points Boston Scientific grew sales and adjusted earnings per share by 16% and 14% in the fourth quarter. However, the company's guidance underwhelmed the market. Ultimately, Boston Scientific's earnings were fine, and its future look... Full story

Yahoo Finance • 3 months ago

Boston Scientific shares slide on cautious 2026 revenue forecast

Feb 4 (Reuters) - Boston Scientific Corp forecast modest 2026 revenue growth and profit just ​below Wall Street expectations on Wednesday, ‌overshadowing a strong fourth-quarter performance and sending its shares down ‌more than 11% in pre... Full story

Yahoo Finance • 3 months ago

Boston Scientific announces results for fourth quarter and full year 2025

MARLBOROUGH, Mass., Feb. 4, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported basis, 14.3 percent on an operational1 b... Full story

Yahoo Finance • 3 months ago

Halper Sadeh LLC Reminds Shareholders of RAPT, PEN, CVGW, FONR of the Firm’s Investigations

NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 3 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)

BALA CYNWYD, Pa., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 4 months ago

Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

ALAMEDA, Calif., Dec. 29, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026.Penumbra, Inc. (PRN... Full story

Yahoo Finance • 6 months ago

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fu... Full story

Yahoo Finance • 6 months ago

Bullish Two Hundred Day Moving Average Cross - PEN

In trading on Monday, shares of Penumbra Inc (Symbol: PEN) crossed above their 200 day moving average of $175.34, changing hands as high as $179.68 per share. Penumbra Inc shares are currently trading up about 10.2% on the day. The chart... Full story

Yahoo Finance • 6 months ago

Penumbra raises 2025 revenue guidance to $1.375B–$1.38B as CAVT and embolization drive growth

Earnings Call Insights: Penumbra, Inc. (PEN) Q3 2025 MANAGEMENT VIEW * Adam Elsesser, Co-Founder, Chairman & CEO, opened by stating, "In the third quarter, we generated total revenue of $354.7 million, representing underlying year-over... Full story